Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...
Adjuvant cemiplimab may reduce the risk of second primary tumors in patients with high-risk cutaneous squamous cell carcinoma, data suggest.
Longitudinally increasing patterns of social media use in children was linked to lower cognitive performance 2 years later.
Early CRP levels may predict progression-free and overall survival among patients with stage IV MM undergoing first-line ICI therapy.
A more dangerous mpox strain, Clade 1, has spread inside the US for the first time after causing thousands of infections in Africa.
HealthDay News — California will start selling low-cost insulin Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for people with ...
The use of ROM terminology on pathology requisition forms has a relatively low positive predictive value for a diagnosis of melanoma.
The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...
The second RZV dose increased immunity against herpes zoster virus outcomes when administered within an extended window after the first dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback